Parvinder K. Aley

Publications by Year

Research Areas

SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Vaccine Coverage and Hesitancy, Calcium signaling and nucleotide metabolism, Immunotherapy and Immune Responses

Most-Cited Works

• → Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK(2020)4,980 cited
• → Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial(2020)2,607 cited
• → Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant(2021)1,318 cited
• → Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection(2021)1,230 cited
• Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial(2020)
• → Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials(2021)1,203 cited
• → SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses(2022)1,007 cited
• → Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial(2021)651 cited
• → T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial(2020)638 cited
• → Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial(2021)540 cited